Stockreport

Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF - Initial data readout from first-line RAS-mutated mCRC randomized CRDF-004 trial expected by the end of 2024- - Projected runway with current cash resources into Q1 [Read more]